To test FLRT3 blockade in vivo, the 293T-FLRT3 CDX tumor model [PD-L1 negative (36)] with adoptively transferred PBMCs was tested with FLRT3 mAb NP591, PD-1 mAb, or both. Here, CD274 is linked to neoplasm.